Article Name Medtech
Aim to bridge healthcare divides worldwide
03rd September, 2024
Clinical trial agreement preludes planned international launch for the mBôs TKA System
02nd September, 2024
Kochi Academy is strategically placed to meet the educational needs of healthcare professionals in Southern India
02nd September, 2024
Advancing personalised medicine has become a key goal for many pharma firms, evident from the rising number of such therapies under clinical development. In 2022 alone, 12 new personalised medicines were approved, marking these treatments as accounting for at least a quarter of new drug approvals over the past eight years. This contrasts sharply with a decade ago when personalised medicines constituted less than 10 per cent of new approvals annually, according to The Personalised Medicine Coalition report. As the trend towards precision medicine and targeted therapies continues, companion diagnostics (CDx) are becoming increasingly vital, particularly in oncology. Let’s explore the opportunities that CDx presents and the hurdles in their development and implementation.
01st September, 2024
To reduce infections, healthcare costs and improve patient outcomes
29th August, 2024
Building blocks for medical supplies, fabrics, etc
28th August, 2024
For use with the GMK Sphere and SpheriKA Knee Systems from Medacta International
29th August, 2024
BS to initiate the launch of the valve system in Europe in coming weeks
27th August, 2024
Specifically tailored for neonates, infants, and young children
29th August, 2024
Expanding market access of anatomic pathology workflow technologies across Europe
28th August, 2024
Fostering innovation in user-centered design
28th August, 2024
Aligns with global efforts in sustainability to reduce reliance on PFAS materials
27th August, 2024
Despite its advantages, broader adoption of simulation technology faces hurdles
26th August, 2024
UQ and ARM Hub partnership accelerates innovation
27th August, 2024
Combining advanced imaging with precise treatment delivery
26th August, 2024
Ease of use, higher efficiency and lower risk of disease transmission in surgical applications
23rd August, 2024
62% planning to invest in generative AI within the next three years, higher than global (56%)
25th August, 2024
Company announces $100 Million in total funding from new and existing investors to advance medical innovation
22nd August, 2024
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer